EMA/HTAs Outline Plans For REAs, Guidelines And Orphans

The European Medicines Agency and the health technology assessment network EUnetHTA are planning to explore ways of improving the timely sharing of EMA assessment reports so that relative effectiveness assessments (REAs) can be developed at an early stage for use for in decision-making by national or local HTA organizations.